Turn Therapeutics (TTRX) Free Cash Flow (2024 - 2026)

Turn Therapeutics' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 436.81% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$3.1 million (changed N/A YoY), while the FY2025 annual figure was -$2.6 million, down 90.99% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$1.6 million, down from -$1.2 million in the prior quarter.
• The five-year high for Free Cash Flow was -$298058.0 in Q1 2025, with the low at -$1.6 million in Q1 2026.
• The 3-year median for Free Cash Flow is -$820272.5 (2024), against an average of -$884650.8.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow sank 181.04% in 2025, then slumped 436.81% in 2026.
• Turn Therapeutics' Free Cash Flow stood at -$430545.0 in 2024, then sank by 181.04% to -$1.2 million in 2025, then tumbled by 32.23% to -$1.6 million in 2026.
• Business Quant data shows TTRX's Free Cash Flow at -$1.6 million in Q1 2026, -$1.2 million in Q4 2025, and -$298058.0 in Q1 2025.